Targeting herpes simplex virus with CRISPR–Cas9 cures herpetic stromal keratitis in mice

Di Yin(Shanghai Jiao Tong University), Yujia Cai(Shanghai Jiao Tong University)
Nature Biotechnology
January 11, 2021
10.1038/s41587-020-00781-8
Cited by 178

Related Papers

Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy
|Nature Nanotechnology|2025|63
A single dose SARS-CoV-2 simulating particle vaccine induces potent neutralizing activities
|bioRxiv (Cold Spring Harbor Laboratory)|2020|10
Immunostimulatory guide RNAs mediate potent antiviral response
|bioRxiv (Cold Spring Harbor Laboratory)|2018|2
Intracorneal delivery of HSV-targeting CRISPR/Cas9 mRNA prevents herpetic stromal keratitis
|bioRxiv (Cold Spring Harbor Laboratory)|2020|0